Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
The Most Encouraging New companies to Look Out For - 2Figure out How to Advance Space in Your Pre-assembled Home for Upgraded Usefulness
- 3The Best Design Bloggers for Style Motivation
- 4Holyvolt And Wildcat Could Help The West Reclaim Battery Leadership
- 54 Sound blocking Earphones for Prevalent Sound and Solace
- Spain’s Picos de Europa: What to see and do in ‘the world’s most beautiful place’
- Zelensky confidant dismissed from further posts amid bribery scandal
- Mysterious bright blue cosmic blasts triggered by black holes shredding stars, scientists say. 'It's definitely not just an exploding star.'
- Telescope in Chile captures stunning new picture of a cosmic butterfly
- Explainer-What will change with the US reclassification of marijuana?
- The Delight of Camper Vans: Choosing the One That Meets Your Requirements
- The Solution to Flexibility: Developing Internal Fortitude Notwithstanding Misfortune
- EU delays signing of Mercosur free trade deal
- How AI fixed the James Webb Space Telescope's blurry vision
